Allergic Rhinitis denials in California external review

In the California DMHC record, independent physician reviewers decided 49 published external-review cases involving allergic rhinitisand overturned the plan’s denial in 36.7%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
49
2003–2026
Overturned
36.7%
18 denials reversed

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
38
44.7%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
10
10%
Typical time to a decision
21 days
Most land between 15 and 24 days
Handled as urgent
14.3%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for sinus surgery (nasal/sinus endoscopy, surgical, with destruction by cryoablation, posterior nasal nerve (PNN) and/or nasal/sinus endoscopy, surgical with destruction by radiofrequency ablation, posterior nerve with the approved septoplasty). The records reflect that the patient suffered from vasomotor rhinitis, also known as non-allergic rhinitis, as well as allergic rhinitis. Symptoms of both include rhinorrhea, postnasal drip, nasal obstruction, which are thought to occur from autonomic nerve dysregulation particularly in the case of vasomotor rhinitis.
Experimental/Investigational · 2025 · IMR EI25-44693
Nature of Statutory Criteria/Case Summary: The parent of an enrollee has requested authorization and coverage for pollen and allergy injections performed weekly for treatment of the enrollee’s allergic rhinitis and asthma. Findings: The physician reviewer found that based on the available documentation, the service of immunotherapy dosed at once weekly intervals meets the current criteria for medical necessity and is within the standard of care for providing immunotherapy injections to a patient who is symptomatic with asthma and allergic rhinitis. Review of the record shows sufficient documentation to support the increased dosing. There was allergy skin testing done with positive findings for several allergens. Clinic notes from provider indicate that the patient was actively taking multiple medications for rhinitis and asthma.
Medical Necessity · 2017 · IMR MN17-27245

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for an allergy skin test. Seidman and colleagues explain that allergic rhinitis is one of the most common disease affecting adults. Clinical practice guidelines report that a diagnosis of allergic rhinitis begins with a directed history and physical examination particularly noting pattern, chronicity, and triggers of symptoms. In this case, the patient has symptoms of intermittent cough, shortness of breath, scratchy throat, and postnasal drip. The records document prior treatment with allergy shots directed by a prior positive skin test, and allergies to tree pollen, weed pollen, dust, and dog dander. The patient had been off all medications since completing allergy shots in 2015.
Medical Necessity · 2022 · IMR MN22-37224
Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for a rhinoplasty primary with major septal repair. This patient has a history of long-standing allergic rhinitis for over 20 years. There is a lack of report or documentation of failure of recent, medically supervised conservative nasal therapy. Physical examination shows only mild tip ptosis and mild septal deviation. The statement by the provider that operative treatment of mild deformity would have an outsized or marked effect in the presence of intranasal swelling is unsupported by peer-reviewed medical literature. Overall, there is a lack of support for the use of the requested procedure in the peer-reviewed medical literature.
Medical Necessity · 2024 · IMR MN24-41155

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving allergic rhinitis, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for allergic rhinitis? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39